Preliminary results from a clinical trial of remdesivir, an experimental antiviral drug being tested for coronavirus, could come in as little as one to two weeks, a top researcher said Sunday.

The final results aren’t expected until mid-to-late May, said Dr. Andre Kalil, a principal investigator for the trial. But he said “we can potentially have some early data in the next one or two weeks,” contingent on a preliminary analysis.

“In the next few weeks, we’re going to do the analysis, and we’re going to basically know if remdesivir is better or not than placebo,” he told CNN.